Amy Reeb
Family · Naperville, ILNPI 1033549894
Payments from drug & device makers
Across 102 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$654
- AstraZeneca$334
- Pfizer$257
- Novo Nordisk$233
- Lilly USA, LLC$128
- Phathom Pharmaceuticals, Inc.$108
- plus $372 from 11 others
What the payments were for
- Food & beverage$2,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $654 |
| AstraZeneca | 17 | $334 |
| Pfizer | 13 | $257 |
| Novo Nordisk | 10 | $233 |
| Lilly USA, LLC | 8 | $128 |
| Phathom Pharmaceuticals, Inc. | 6 | $108 |
| Supernus Pharmaceuticals, Inc. | 4 | $101 |
| Amgen | 4 | $97 |
| Exact Sciences | 2 | $36 |
| Abbott | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| GSK | 1 | $17 |
| Viatris Specialty LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,087 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $38,140 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $6,603 |
| Valsartan | 71 | $2,455 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 24 | $1,691 |
| Potassium Citrate ErPotassium Citrate | 39 | $1,384 |
| Levothyroxine Sodium | 96 | $1,148 |
| Memantine Hcl ErMemantine Hcl | 20 | $1,133 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,128 |
| Atorvastatin Calcium | 132 | $1,120 |
| SynthroidLevothyroxine Sodium | 14 | $1,071 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $799 |
| Amlodipine Besylate | 107 | $783 |
| Memantine Hcl | 19 | $680 |
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 12 | $656 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $233 | $38,14029 claims |
| AbbVieSynthroid | $654 | $1,07114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.
Other family in Naperville
- Erin SieberNaperville$334K
- Rachel SulfridgeNaperville$13K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.